Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
$1.59B |
| 2 |
Microchip Technology
MCHP
|
$691M |
| 3 |
Microsoft
MSFT
|
$586M |
| 4 |
PepsiCo
PEP
|
$510M |
| 5 |
Sunoco
SUN
|
$454M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$793M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
$490M |
| 3 |
NS
NuStar Energy L.P.
NS
|
$431M |
| 4 |
Flutter Entertainment
FLUT
|
$424M |
| 5 |
UDR
UDR
|
$419M |
Sector Composition
| 1 | Technology | 25.82% |
| 2 | Financials | 11.96% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 10.48% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Melco Resorts & Entertainment
MLCO
$3.95B
| $90.5K | ﹤0.01% |
12,132
-1,928
| -14% | -$14.4K |
|
3652
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $90.1K | ﹤0.01% |
52,101
+4,788
| +10% | +$8.28K |
|
3653
LivePerson
LPSN
$86M
| $88.9K | ﹤0.01% |
153,144
-55,054
| -26% | -$32K |
|
3654
Actinium Pharmaceuticals
ATNM
$53.3M
| $88.8K | ﹤0.01% |
12,000
+474
| +4% | +$3.51K |
|
3655
United Homes Group
UHG
$238M
| $88.3K | ﹤0.01% |
15,520
+4,772
| +44% | +$27.2K |
|
3656
Avita Medical
RCEL
$116M
| $86.9K | ﹤0.01% |
10,978
+4
| +0% | +$32 |
|
|
PSTX
3657
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $86.7K | ﹤0.01% |
29,689
-1,542
| -5% | -$4.5K |
|
|
BLUE
3658
DELISTED
bluebird bio
BLUE
| $86.5K | ﹤0.01% |
87,891
+6,119
| +7% | +$6.02K |
|
|
PPTA
3659
Perpetua Resources
PPTA
$2.07B
| $86.4K | ﹤0.01% |
16,611
+4
| +0% | +$21 |
|
|
BZUN
3660
Baozun
BZUN
$233M
| $84.9K | ﹤0.01% |
+36,292
| New | +$84.9K |
|
3661
MMTec
MTC
$23.9M
| $83.3K | ﹤0.01% |
163,352
+75,576
| +86% | +$38.5K |
|
3662
Wheels Up
UP
$1.63B
| $81.8K | ﹤0.01% |
+43,279
| New | +$81.8K |
|
|
GTHX
3663
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $81.4K | ﹤0.01% |
+35,709
| New | +$81.4K |
|
3664
Sera Prognostics
SERA
$129M
| $78.9K | ﹤0.01% |
13,320
-608,514
| -98% | -$3.6M |
|
3665
Erasca
ERAS
$406M
| $77.4K | ﹤0.01% |
32,811
+3,557
| +12% | +$8.4K |
|
3666
Sutro Biopharma
STRO
$85.6M
| $76.9K | ﹤0.01% |
26,261
+61
| +0.2% | +$179 |
|
|
KG
3667
Kestrel Group, Ltd.
KG
$198M
| $76.9K | ﹤0.01% |
37,313
-4,416
| -11% | -$9.06K |
|
3668
Zevra Therapeutics
ZVRA
$501M
| $76.6K | ﹤0.01% |
15,632
-287
| -2% | -$1.41K |
|
3669
Achieve Life Sciences
ACHV
$146M
| $76.2K | ﹤0.01% |
+16,214
| New | +$76.2K |
|
|
CONN
3670
DELISTED
Conn's Inc.
CONN
| $76K | ﹤0.01% |
68,769
+781
| +1% | +$863 |
|
|
NXDT
3671
NexPoint Diversified Real Estate Trust
NXDT
$177M
| $74.7K | ﹤0.01% |
13,506
-29,435
| -69% | -$163K |
|
|
INZY
3672
DELISTED
Inozyme Pharma
INZY
| $73.2K | ﹤0.01% |
16,404
-1,980
| -11% | -$8.83K |
|
3673
Pyxis Oncology
PYXS
$91.2M
| $73.2K | ﹤0.01% |
+22,103
| New | +$73.2K |
|
|
NIU
3674
Niu Technologies
NIU
$341M
| $72.5K | ﹤0.01% |
+41,644
| New | +$72.5K |
|
3675
Shattuck Labs
STTK
$61.3M
| $71.4K | ﹤0.01% |
+18,490
| New | +$71.4K |
|